fool.com · Aug 18, 2026
New York Stock Exchange (NYSE)
Tertunda 15 menit
Liputan Bristol-Myers Squibb Company
Berita terbaru Bristol-Myers Squibb Company
Berita pasar
Seputar pasar
zacks.com · Aug 14, 2026
Can BMY's First CELMoD Approval Support Its Growth Strategy?
Baca artikel →
fool.com · Aug 14, 2026
AbbVie vs. Bristol-Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026?
Baca artikel →
fool.com · Aug 14, 2026
Fidelity Healthcare ETF vs. iShares Pharma Fund: Which Wins?
Baca artikel →
fool.com · Aug 13, 2026
Is the Reported $400 Billion AstraZeneca-Bristol Myers Squibb Megamerger a Slam Dunk -- or a Disaster Waiting to Happen?
Baca artikel →
businesswire.com · Aug 13, 2026
U.S. FDA Grants Accelerated Approval to Bristol Myers Squibb's First CELMoD Therapy ZENBEXUS™, in Combination with Daratumumab and Hyaluronidase-fihj and Dexamethasone (ZDd) for Patients with Multiple Myeloma, as Early as First Relapse
Baca artikel →Data utama
Ringkasan keuangan
Tren pendapatan, profitabilitas, neraca, arus kas, dan valuasi untuk Bristol-Myers Squibb Company.
NYSE MARKET COMPARABLES
Perusahaan serupa
Ten established NYSE listings presented for broader market context.
Referensi NYSE
Tertunda 15 menit
BRK.B
Berkshire Hathaway
Diversified holdings
→
LLY
Eli Lilly
Pharmaceuticals
→
JPM
JPMorgan Chase
Banking
→
V
Visa
Payments
→
WMT
Walmart
Consumer retail
→
XOM
Exxon Mobil
Energy
→
JNJ
Johnson & Johnson
Healthcare
→
MA
Mastercard
Payments
→
ORCL
Oracle
Enterprise software
→
HD
Home Depot
Consumer retail
→
TradingView menampilkan tabel data pasar. Securities.io hanya menyediakan pilihan pembanding editorial, label perbandingan, dan tautan tujuan.
Riset Securities.io
Lanjutkan riset Anda
Data pasar NYSE di halaman ini diberi label tertunda 15 menit. Harga, grafik, data keuangan, informasi perusahaan, dan perbandingan dengan perusahaan sejenis ditampilkan oleh TradingView; Securities.io tidak mengambil nilai-nilai tersebut. Informasi ini hanya untuk tujuan edukasi dan bukan merupakan nasihat investasi.